Skip to main content

Monitoring

0
Pipeline Programs
2
Companies
3
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

GE HealthCare
2 programs
Clinical Performance and Usability of the Heart Rate and Impedance Respiration Monitor CableN/A1 trial
Continuous MonitoringN/A1 trial
Active Trials
NCT07893405Recruiting50Est. Dec 2026
NCT07309809Not Yet Recruiting50Est. Oct 2026
Philips
PhilipsNetherlands - Amsterdam
1 program
Wearable SensorN/A1 trial
Active Trials
NCT05181111Completed400Est. Nov 2023

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
GE HealthCareContinuous Monitoring
GE HealthCareClinical Performance and Usability of the Heart Rate and Impedance Respiration Monitor Cable
PhilipsWearable Sensor

Clinical Trials (3)

Total enrollment: 500 patients across 3 trials

NCT07309809GE HealthCareContinuous Monitoring

Portrait Mobile Monitoring Solution V2.0 External Evaluation

Start: Jul 2026Est. completion: Oct 202650 patients
N/ANot Yet Recruiting
NCT07893405GE HealthCareClinical Performance and Usability of the Heart Rate and Impedance Respiration Monitor Cable

Clinical Performance and Usability of the Heart Rate and Impedance Respiration Monitor Cable

Start: Apr 2026Est. completion: Dec 202650 patients
N/ARecruiting
NCT05181111PhilipsWearable Sensor

Continuous Monitoring of Patients in and After the Acute Admission Ward to Optimize Clinical Pathways

Start: Dec 2021Est. completion: Nov 2023400 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 actively recruiting trials targeting 500 patients
2 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.